OMRON Healthcare showcases heart health innovations at CES 2021

OMRON Healthcare showcases heart health innovations at CES 2021

Introducing its first remote patient monitoring service in the U.S. and previewing a new app with expanded featured and personalization options.

Hoofddorp, The Netherlands – OMRON Healthcare Co. proudly announces its presence at the very first ‘all digital’ CES 2021, from January 11 to 14. Among other breakthrough innovations, OMRON Healthcare will be showcasing VitalSight™, the new Remote Patient Monitoring (RPM) available in the U.S., which enhances patient-to-physician communication. Alongside with this, the company will unveil the OMRON connect 2.0 mobile app, to empower consumers to actively manage their heart health. With these innovations, OMRON Healthcare takes one step further in enabling consumers around the world to lead healthier and more actives lives.

VitalSight

According to the American Heart Association national blood pressure guidelines, 116 million U.S. adults are in the hypertensive range1 and the CDC reports that 37 million of them have uncontrolled Stage 2 hypertension2 with a higher risk of heart attack and stroke. In parallel, the European Society of Hypertension estimates that the prevalence of hypertension in Europe is around 33%3. For those at the higher end of the hypertension scale, that risk is even higher during the pandemic as health care system are overwhelmed and hypertension is an underlying health condition carrying greater risk of complications from COVID-194.

In order to improve health outcomes in the management of hypertension, OMRON is accelerating the development of RPM systems such as VitalSight to encourage more remote monitoring, enhance communication between the patient and the physician, and enable data-driven treatment decisions.

With VitalSight, patients receive a kit delivered to their home that includes an OMRON connected blood pressure monitor and data hub that are pre-set to securely share measurements with the patient’s physician and care team. VitalSight can be integrated with the clinician’s Electronic Medical Record (EMR) system or through the OMRON Doctor Dashboard for easy data analysis, which provides automatic notifications to signal when a patient has readings that require action to be taken.

The need for this type of services was already great before the pandemic, and now it’s even more urgent. OMRON is partnering with the most forward-thinking health systems around the world, including the NHS in the UK, to accelerate the rollout of RPM systems, allowing doctors and patients to build comprehensive insights into their heart’s health, and the reassurance that general practitioners have the full picture when prescribing medication and following up treatment plans.

OMRON connect 2.0

OMRON executives in the U.S. are also previewing the new OMRON connect 2.0 mobile app at CES, which will sync with every connected blood pressure monitor from the brand and will serve as a personal heart health coach with expanded insights based on blood pressure readings and incentives for heart-healthy behavior change.

Current OMRON apps, HeartAdvisor™ and OMRON connect, will merge into OMRON Connect 2.0, allowing for more personalization options and an extended range of features, vastly increasing the value of every OMRON connected blood pressure monitor. All OMRON connected devices, including HeartGuide and OMRON’s recently redesigned line of blood pressure monitors, will pair with OMRON connect 2.0.

OMRON connect 2.0 will be available to download on the Apple iTunes and Google Play later in 2021.

Going For Zero cardiovascular events

We’ve applied over 40 years of category leadership, research, development, consumer feedback, and physician insights to the innovations OMRON has been gradually introducing at CES. In spite of the difficulties of the context, we’re proud that 2021 is no exception. We continue evolving our Going for Zero mission, seeking to help those struggling to manage hypertension and its risks, especially with comorbidities and complications associated with this COVID-19 pandemic.

For CES 2021 registered attendees only

CES 2021 registered attendees and invited media outlets can follow OMRON Healthcare’s keynote speakers and presentations using the following links.

• CES 2021

Jan. 11-14, 2021

https://digital.ces.tech/home

*Jan. 11 is Media Day, exclusive for media representatives.

• Media Day for OMRON Healthcare

Jan 11, 2:00 PM-3:00PM（EST）- 20:00 – 21:00 Hs. (CET)

Theme: “Efficacy of the Remote Patient Monitoring including VitalSight from the standpoint of a physician and a health economist”, “Latest information of OMRON Connect 2.0., our health APP”

Topics:

– Dr Percell, director of the Institute at Northwestern with whom OMRON has developed VitalSight will discuss the possibility of Remote Patient Monitoring service.

– Correlation of VitalSight and economy will be discussed by Healthcare Economist.

– A prospect of hypertensive management and the vision of remote patient monitoring service will be introduced along with a testimonial by a hypertensive patient who joined our 90-days blood pressure management program.

– Detail of the new OMRON Connect 2.0 health mobile app will be revealed.

Speakers

Dr. Stephen Percell (Director of the Institute for Public Health and Medicine at Northwestern), Frederick Goodall (Founder of MochaManStyle), Sarasohn-Kahn (Health Economist), Ranndy Kellogg, Jeff Ray, Carol Lucarelli（Omron Healthcare, Inc. Our U.S. representatives.

• Live programs

1. Introducing VitalSight by OMRON (Latest practice of our RPM in the U.S.)

Jan.12, 12:15 PM-12:45 PM（EST) – 18:15-18:45 Hs. (CET)

URL: https://digital.ces.tech/sessions/3ef069f0-01e0-4020-b243-9de98ec0ac04?source=sessions

2. Going for Zero: The Heart of Everything We Do

Jan.13, 11:30 AM-12:00 PM（EST) – 17:30 – 18:00 hs. (CET)

1 billion adults globally are hypertensive, including 116 million in the U.S. For better blood pressure management, OMRON introduced HeartGuide, the first wearable blood pressure monitor (BP monitor) in 2019, and Compete, the first BP monitor with ECG, and now VitalSight. We will introduce how these innovative technologies and devices contribute to the BP management. Our OMRON Connect 2.0 APP will also be introduced during the session.

URL: https://digital.ces.tech/sessions/e94ce5af-a111-492e-9260-e22341cf47b0?source=%2Ffavorites

3. The Trade-Off Between Staying Secure and Staying Healthy

Jan.13, 5:45 PM-6:15 PM（EST）- 23:45 – 00:15 Hs. (CET)

＊Ranndy Kellogg from OMRON Healthcare, Inc. will join as a panelist.

URL: https://digital.ces.tech/sessions/fa4572f8-903f-431d-9038-325019f25c64?source=sessions

To learn more about our global activities regarding remote patient monitoring service, evolution of BP management and the practices of new cardiovascular condition management, please visit http://healthcare.omron.com/ces

About OMRON Healthcare Europe

Committed to helping people live more active and fulfilling lives with zero compromise, OMRON Healthcare is a global leader in the field of clinically proven, innovative medical equipment for health monitoring and therapy.

Throughout its 87-year history OMRON Healthcare has been striving to improve lives and contribute to a better society by developing innovations that help people prevent, treat and manage their medical conditions, both at home and in clinical practice in over 117 countries.

OMRON Healthcare is the No. 1 brand recommended by cardiologists in Europe for blood pressure monitors and the Global No. 1 brand in nebulisers for respiratory treatment with over 30 million devices sold. The company’s additional core product categories are low-frequency pain therapy equipment, body composition monitors and electronic thermometers.

OMRON Healthcare Group is headquartered in Kyoto, Japan. OMRON Healthcare Europe B.V. is the healthcare division for Europe, Russia, Middle East and Africa and provides services to customers in more than 74 countries.

References:

1 American Heart Association: Is high blood pressure inevitable? Here’s how to keep it in check
2 CDC
3 PubMed
4 American Heart Association: COVID-19 Newsroom